BIOCORRX INC (BICX:OTCMKTS)
$0.337 -0.033 (-8.9189%)
Analysed BIOCORRX INC (BICX:OTCMKTS) News Sources
BioCorRx Reports 3,985% Revenue Growth to $313K in the First Half of 2025 Driven by LUCEMYRA(R) (lofexidine) Sales
14-08-2025
yahoo.com
Diamond Equity Research Initiates Coverage on BioCorRx速, Inc. (OTCQB: BICX)
25-08-2025
yahoo.com
BioCorRx, Inc. Announces Q3 2025 Results: Second Straight Quarter of Meaningful Revenue Driven by LUCEMYRA(R) Acquisition
18-11-2025
yahoo.com
Life Sciences Virtual Investor Forum Agenda Announced for December 11th
09-12-2025
yahoo.com
BioCorRx Inc. to Present at the Life Sciences Virtual Investor Forum December 11th
10-12-2025
yahoo.com
BioCorRx Provides Update on OTC Markets Quotation Status and Planned Form S1 Filing
24-12-2025
yahoo.com
BioCorRx Announces Appointment of Louis Lucido as Board Chair
06-01-2026
yahoo.com
BioCorRx, Inc. Announces Initiation of Clinical Study by Majority-Owned Subsidiary BioCorRx Pharmaceuticals, Inc. Evaluating Long-Acting Naltrexone Implant With or Without Bupropion
14-01-2026
yahoo.com
BioCorRx, Inc. Announces Issuance of U.S. Patent Supporting Its Biodegradable Naltrexone Implant Technology
11-03-2026
yahoo.com
What is the current price of BIOCORRX INC (BICX:OTCMKTS)?
The current price of BIOCORRX INC (BICX:OTCMKTS) is $0.337.
BIOCORRX INC (BICX:OTCMKTS) absolute price change since previous trading day?
The absolute price change of BIOCORRX INC (BICX:OTCMKTS) since the previous trading day is $-0.033.
BIOCORRX INC (BICX:OTCMKTS) percentage price change since previous trading day?
The percentage price change of BIOCORRX INC (BICX:OTCMKTS) since the previous trading day is -8.9189%.
What is the most recent average sentiment score for BIOCORRX INC (BICX:OTCMKTS)?
The most recent average sentiment score for BIOCORRX INC (BICX:OTCMKTS) is 64 out of 100.
What is the most recent average sentiment for BIOCORRX INC (BICX:OTCMKTS)?
The most recent sentiment for BIOCORRX INC (BICX:OTCMKTS) is .
SEC-8K** Filing Available For BIOCORRX INC (BICX:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.